thalidomide has been researched along with Uterine Cervical Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, H; Li, S; Liu, C; Song, L; Wu, Y; Yang, L | 1 |
| Downs, LS; Ramakrishnan, S; Rogers, LM; Yokoyama, Y | 1 |
| Napalkov, NP | 1 |
1 review(s) available for thalidomide and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
[Transplacental carcinogenesis].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Abnormalities, Drug-Induced; Adenocarcinoma; Animals; Carcinogens; Cricetinae; Diethylstilbestrol; Embryo, Mammalian; Female; Gestational Age; Humans; Inactivation, Metabolic; Maternal-Fetal Exchange; Mice; Neoplasms; Neoplasms, Experimental; Nitroso Compounds; Organ Culture Techniques; Pregnancy; Rats; Teratogens; Thalidomide; Uterine Cervical Neoplasms; Vaginal Neoplasms | 1977 |
2 other study(ies) available for thalidomide and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer.
Topics: Cisplatin; Drug Synergism; Female; Humans; Janus Kinase 1; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor; Thalidomide; Uterine Cervical Neoplasms | 2022 |
Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer.
Topics: Angiogenesis Inhibitors; Angiostatins; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Endothelial Cells; Female; Fibroblast Growth Factor 2; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Random Allocation; Recombinant Proteins; Thalidomide; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2005 |